Hall KS, Trussell J, Schwarz EB: Progestin-only contraceptive pill use among women in the United States. Contraception 86(6):653,n2012 Hannaford PC, Selvaraj 5, Elliott M, et al: Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners' oral contraception study. BMJ 335:651, 2007 Haring T, Mulders TMT: The combined contraceptive ring NuvaRing® and spermicide co-medication. Contraception 6 :271, 2003 Harrison-Woolrych M, Ashton J, Coulter 0: Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported? Contraception 67:53, 2003 Heinemann K, Reed 5, Moehner 5: Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception 91(4):274, 2015 Heinemann LA, Weimann A, Gerken G, et al: Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 3: 194, 1998 Hidalgo MM, Lisondo C, Juliato CT, et al: Ovarian cysts in users ofImplanon and Jadelle subdermal contraceptive implants. Contraception 73(5):532, 2006 Horron LG, Simmons KB, Curtis M: Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review. Contraception 94(6):590 2016 Hubacher 0, Lara-Ricalde R, Taylor OJ, et al: Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 345:561, 2001 Hubacher 0, Reyes V, Lillo 5, et al: Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 195(5):1272,n2006 International Collaboration of Epidemiological Studies of Cervical Cancer: Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370: 1609, 2007